Transphagocytic CD4+ T cells are true APC capable of inducing functional CD8 memory cells


Confocal Microscopy Image of naive CD8+ and LIST-OVA-specific CD4 T cells

Confocal Microscropy Image of naive CD8+ and LIST-OVA-specific CD4 T cells (Figure 3d, Cruz Adalia)

CD8 T cells mediate defences against intracellular microbes and cancer via the recognition of antigen on major histocompatibility complex I (MHC-I), a molecule expressed by all almost cell types. However, professional antigen presenting cells (APCs) such as Dendritic cells (DCs), macrophages and B cells are responsible for priming functional CD8 T cells.

CD4 T cells are well known as T helper cells and potentially necessary for the generation of functional memory CD8+ T cells, however the exact mechanism of this is unknown.CD4 T cells undergo transphagocytosis, a process by which CD4 T cells capture bacteria from DCs. Transphagocytic CD4 T cells (tpCD4) have the ability to kill internalised bacteria, and it is suggested that this mechanism could be used to present antigen to other cells via MHC-I. Cruz-Adalia et al. aimed to determine if tpCD4 T cells are true APCs and have the ability to prime functional memory CD8+ T cells.

Cruz-Adalia et al. demonstrate that tpCD4 T cells can present antigens to naïve CD8+ T cells inducing proliferation by 2 days of co-culture with high expression of activation molecules, CD25 and CD69. This priming mechanism is dependent on internal MHC-1 pathway, and not sampling of antigens pre-loaded on to MHC-1 from DCs. CD8+ T cells primed via tpCD4 T cells expressed relatively high levels of CD127, CD62L and CD44, with low expression of PD-1. Additionally, CD8+ T cells primed by tpCD4 T cells have the ability to control Listeria monocytogenes infection, and control cancerous growth with reduced tumour size and increased survival of 67% compared to 0% in control mice.

In summary, Cruz-Adalia et al. demonstrated that tpCD4 T cells are capable of priming naïve CD8 T cells, that have a predominantly central memory profile with low PD-1 expression. Additionally, the ability of CD8 T cells primed by tpCD4 T cells to restrict tumour growth, make tpCD4+ T cells a potential cancer therapeutic.

Journal Article: Cruz-Adalia et al. 2017. Conventional CD4+ T cells present bacterial + antigens to induce cytotoxic and memory CD8 T cell responses. Nature Communications.

 

Article by Cheleka AM Mpande

 
 
 
 
 
 
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineScience Education PrizesElizabeth Glazer Pediatric Aids Foundation
 

Accessibility Toolbar